Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00277108 · ClinicalTrials.gov registry record · NA
Lexapro in the Treatment of Patients With Postpartum Depression
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00277108 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 20 participants.
The verdict
NCT00277108, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Escitalopram (Lexapro) is effective in the treatment of postpartum depression.
Interventions
- DRUG Escitalopram (Lexapro)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-02 |
| Est. Completion | 2007-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00277108
The ClinicalTrials.gov registry entry for NCT00277108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Escitalopram (Lexapro) is the first listed.
NCT00277108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00277108 about?
NCT00277108 is a clinical study titled "Lexapro in the Treatment of Patients With Postpartum Depression". The purpose of this study is to determine if Escitalopram (Lexapro) is effective in the treatment of postpartum depression.
What is the current status of trial NCT00277108?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2004-02. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00277108?
The interventions under investigation include: Escitalopram (Lexapro) (DRUG).
Who is sponsoring clinical trial NCT00277108?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.